Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1597 of 6351
-
Could diabetes drugs be the key to halting heart disease?
Disease control Recruiting nowThe purpose of the study is to compare the anti-atherosclerotic efficacy of oral treatment with a GLP-1 analogue (semaglutide) or an SGLT-2 (so-called "flozin") inhibitor (dapagliflozin) versus routine treatment (metformin) in patients with pre-diabetes and diagnosed coronary art…
Phase 4 • Sponsor: National Institute of Cardiology, Warsaw, Poland • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could a broader vitamin mix outperform standard prenatal supplements?
Disease control CompletedMicronutrient deficiencies during pregnancy may affect the mother's nutritional status and the baby's growth. This study compared two types of daily supplements for pregnant women: a multiple micronutrient supplement and an iron and folic acid supplement. Pregnant women in Indon…
Sponsor: Indonesia Timur University • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a new drug combo flush out hidden HIV?
Disease control OngoingThis study investigates the use of VH3810109 with or without FTR to reduce the size and activity of the HIV viral reservoir in two sub-populations of people living with HIV: treatment-naïve adults (Population 1) and treatment-experienced adults currently taking a standard of care…
Phase 1 • Sponsor: ViiV Healthcare • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Can a hormone drug boost exercise benefits for aging HIV patients?
Disease control Recruiting nowPeople with HIV experience earlier impairments in physical function compared to people in the general population. They also exhibit an earlier presentation and more rapid development of frailty, a multisystemic syndrome of aging characterized by reduced activity, fatigue, slownes…
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Can a Single-Step dental implant restore smiles in the very old?
Disease control By invitation onlyBackground: In recent years, dental implants have become a popular and effective option for replacing missing teeth, even in older adults. However, there is still limited research on implant treatments in patients aged 80 and older. Study Details: In this study, we evaluated an …
Sponsor: Takane Dental Clinic • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New drug cocktail aims to fight Hard-to-Treat cancers
Disease control Recruiting nowThis is a phase I/II study to preliminarily explore of the safety, tolerability, pharmacokinetics, and efficacy of WJB001 combination therapy, consisting of three stages: Dose escalation (Phase Ia), dose extension (Phase Ib), and efficacy extension (Phase II). The preliminary pla…
Phase 1/2 • Sponsor: Wigen Biomedicine Technology (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Exercise and diet combo shows promise for stiff arteries in hypertension
Disease control CompletedCardiovascular disease (CVD) is one of the leading causes of mortality worldwide and a major risk factor for morbidity worldwide . It is necessary to reduce the incidence and risk factors of CVD, as physical activity is known to reduce mortality from CVD. Arterial stiffness and h…
Sponsor: Deraya University • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Robot bronchoscopy could spot lung cancer earlier
Diagnosis Recruiting nowWhat is this study about? This study tests a new robotic technology to take tissue samples from lung nodules (small spots in the lungs). Some lung nodules are cancer, but doctors need a tissue sample to know for sure. What is the problem? Current methods to get tissue from lung …
Sponsor: Ulsan University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
New combo therapy targets tough tumors
Disease control Recruiting nowThis study aims to evaluate the safety and tolerability of HRS-7058 combined with antitumor drugs in subjects with solid tumors, and to determine the recommended dosage for Phase II. Evaluate the objective response rate of HRS-7058 in combination with anti-tumor drugs in subjects…
Phase 2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Freezing nerve treatment could replace surgery for stroke foot deformity
Symptom relief Recruiting nowCRYOSTROKE study is designed : * to compare the efficacy and safety of percutaneous CryoNeurotomie (CN) versus surgical neurotomy (SN) on spasticity, 90 days after intervention, in post-stroke patients presenting with spastic equinovarus foot and, * to ensure that potential clin…
Sponsor: Poitiers University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
New pill TJ0113 hopes to lift depression in 8 weeks
Symptom relief CompletedThis study is a phase II, randomized, double-blind, multi-center, placebo-controlled, parallel-group clinical trial and 150 subjects with depressive disorder will be enrolled. Subjects will be randomly assigned in a 1:1 ratio to two cohorts (Cohort 1: 200 mg dose group; Cohort 2:…
Phase 2 • Sponsor: Hangzhou PhecdaMed Co., Ltd. • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
New HIV drug shows promise in early trial to lower virus levels
Disease control CompletedThis study will examine if at least one dose level of MK-4646 can lower HIV-1 viral load in a person's blood by a certain amount. The goals of this study are to learn about the safety of MK-4646 and if people tolerate it; and how HIV-1 viral load may decrease after starting to ta…
Phase 1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a common antidepressant ease rett syndrome?
Disease control Recruiting nowRett Syndrome (RTT) is a rare neurodevelopmental disorder caused by an MECP2 gene mutation on the X chromosome, primarily affecting females. It causes progressive motor and cognitive decline, loss of speech, repetitive hand movements, breathing issues, seizures, and sleep problem…
Phase 2 • Sponsor: University of Trieste • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Pill combo offers new hope for rural head and neck cancer patients
Disease control Recruiting nowThis phase II trial gathers information on the feasibility, safety, and effect of giving methotrexate, erlotinib, and celecoxib in treating head and neck cancer that has come back after a period of improvement (recurrent) or that has spread from where it first started (primary si…
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Digital assistant aims to close gaps in hereditary cancer care
Disease control By invitation onlyThe goal of this clinical trial is to address care gaps for participants at high risk of breast and ovarian cancer (HBOC), or Lynch syndrome (LS) because of testing positive for specific genetic variants. A patient-centered clinical decision support (PC-CDS) tool will help identi…
Sponsor: HealthPartners Institute • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
A cup of lavender tea a day may keep PMS blues away — science puts it to the test
Symptom relief CompletedPremenstrual syndrome (PMS) is a common but complex condition defined as a combination of emotional, psychological, and physical symptoms that occur during the luteal phase of the menstrual cycle, usually between 2 and 14 days before the onset of menstruation, and that diminish w…
Sponsor: Sakarya University • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
Dialysis patients may soon say goodbye to strict low-potassium diets
Disease control Recruiting nowThis is a phase III, prospective, randomized, double-blind, placebo-controlled, single-center, pilot trial, aimed at assessing whether treatment with the oral potassium binder patiromer as compared to placebo allows withdrawal or down-titration of potassium dietary restriction wi…
Phase 3 • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Disease control
Last updated Jun 26, 2026 14:09 UTC
-
Herbal granules aim to slow eye disease in major trial
Disease control Recruiting nowThis is a phase III randomized, double-masked, placebo-controlled, multicenter study. To evaluate the efficacy and safety of QA108 granules in the treatment of intermediate age-related macular degeneration.
Phase 3 • Sponsor: Smilebiotek Zhuhai Limited • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Could a super multivitamin give babies a healthier start in life?
Disease control Recruiting nowThis clinical trial aims to learn if MMS Plus improves infant health compared to standard MMS during pregnancy and the postnatal period in women living in peri-urban areas of Karachi, Pakistan. It will also evaluate how MMS Plus affects infant growth during the first 6 months of …
Phase 3 • Sponsor: Aga Khan University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New pill could ease rare skin disease
Disease control Recruiting nowThe trial is conducted in order to assess the safety of KM-023 and to observe what effects, both beneficial and adverse, it has on the body, and the way the body absorbs and eliminates KM-023, first in healthy participants, then in Olmsted Syndrome patients. In addition, the stud…
Phase 1 • Sponsor: Orvida Pharma (formerly Kamari Pharma) • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC